Literature DB >> 12646780

Ischaemic cerebrovascular events in HIV infection: a cohort study.

Stefan Evers1, Darius Nabavi, Alexandra Rahmann, Christoph Heese, Doris Reichelt, Ingo-W Husstedt.   

Abstract

Several case reports and series described ischaemic cerebrovascular events in HIV infection. However, the exact prevalence and the clinical features of these events are unknown. We performed a cohort study on 772 consecutive HIV infected patients and evaluated the rate of transient ischaemic attacks (TIA) and of completed stroke. A total prevalence of 1.9% for TIA (0.8%) and stroke (1.2%) was calculated resulting in an annual incidence rate of 216 per 100000. The prevalence was highest in the later stages of the infection. Stroke patients had a poorer immunological state than the TIA and the cohort patients. Probable (n = 3) and possible (n = 2) vasculitis and cardiogenic embolism (n = 2) could be detected as aetiology, the remaining patients had a cryptogenic event. Our data suggest that ischaemic cerebrovascular events are more common in HIV infected patients than in the general population and that a part of these events might be caused by HIV associated vasculitis or vasculopathy. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646780     DOI: 10.1159/000068828

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  16 in total

1.  Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals.

Authors:  Felicia C Chow; Richard W Price; Priscilla Y Hsue; Anthony S Kim
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-03-02       Impact factor: 2.136

2.  Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects.

Authors:  Souvik Sen; Hongyu An; Prema Menezes; Jonathan Oakes; Joseph Eron; Weili Lin; Kevin Robertson; William Powers
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-05-05       Impact factor: 2.136

Review 3.  Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy.

Authors:  Belinda Cruse; Lucette A Cysique; Romesh Markus; Bruce J Brew
Journal:  J Neurovirol       Date:  2012-04-14       Impact factor: 2.643

4.  Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men.

Authors:  Farrah J Mateen; Wendy S Post; Ned Sacktor; Alison G Abraham; James T Becker; Bryan R Smith; Roger Detels; Eileen Martin; John P Phair; Russell T Shinohara
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

5.  Stroke in patients with human immunodeficiency virus infection.

Authors:  Brent Tipping; Linda de Villiers; Helen Wainwright; Sally Candy; Alan Bryer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

Review 6.  [Epidemiology and therapy of pain and depression during HIV and AIDS].

Authors:  I W Husstedt; D Reichelt; F Kästner; S Evers; K Hahn
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

7.  Restricted Diffusion of Pus in the Subarachnoid Space: MRSA Meningo-Vasculitis and Progressive Brainstem Ischemic Strokes - A Case Report.

Authors:  David Z Rose; Carlos Parra-Herran; Carol K Petito; M Judith D Post
Journal:  Case Rep Neurol       Date:  2010-08-07

8.  Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis.

Authors:  Wilhelm Küker; Susanne Gaertner; Thomas Nagele; Christian Dopfer; Martin Schoning; Jens Fiehler; Peter M Rothwell; Ulrich Herrlinger
Journal:  Cerebrovasc Dis       Date:  2008-05-30       Impact factor: 2.762

9.  Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort.

Authors:  Felicia C Chow; Wei He; Peter Bacchetti; Susan Regan; Steven K Feske; James B Meigs; Steven K Grinspoon; Virginia A Triant
Journal:  Neurology       Date:  2014-10-03       Impact factor: 9.910

10.  Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.

Authors:  Isabel M Elicer; Desiree Byrd; Uraina S Clark; Susan Morgello; Jessica Robinson-Papp
Journal:  J Neurovirol       Date:  2018-04-25       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.